Excellent report.....better hurry up @druce buying script......the only direction is up now
Good manufacturing numbers coming through
Good sales ......ramping up nice revenue so far
Two new patents filed.....no doubt at least one referring to radiotherapy
The most important new information below means we will be going into phase 2 with data to be published shortly
The dose escalation phase for DEP® cabazitaxel is approaching completion with multiple patients displaying efficacy signals, including stable disease of more than 47 weeks and significant reductions in specific tumour biomarkers, such as prostate specific antigen
